Torrente-López, A.; Hermosilla, J.; Salmerón-GarcÃa, A.; Cabeza, J.; Navas, N.
Comprehensive Analysis of Nivolumab, A Therapeutic Anti-Pd-1 Monoclonal Antibody: Impact of Handling and Stress. Pharmaceutics 2022, 14, 692.
https://doi.org/10.3390/pharmaceutics14040692
AMA Style
Torrente-López A, Hermosilla J, Salmerón-GarcÃa A, Cabeza J, Navas N.
Comprehensive Analysis of Nivolumab, A Therapeutic Anti-Pd-1 Monoclonal Antibody: Impact of Handling and Stress. Pharmaceutics. 2022; 14(4):692.
https://doi.org/10.3390/pharmaceutics14040692
Chicago/Turabian Style
Torrente-López, Anabel, Jesús Hermosilla, Antonio Salmerón-GarcÃa, José Cabeza, and Natalia Navas.
2022. "Comprehensive Analysis of Nivolumab, A Therapeutic Anti-Pd-1 Monoclonal Antibody: Impact of Handling and Stress" Pharmaceutics 14, no. 4: 692.
https://doi.org/10.3390/pharmaceutics14040692
APA Style
Torrente-López, A., Hermosilla, J., Salmerón-GarcÃa, A., Cabeza, J., & Navas, N.
(2022). Comprehensive Analysis of Nivolumab, A Therapeutic Anti-Pd-1 Monoclonal Antibody: Impact of Handling and Stress. Pharmaceutics, 14(4), 692.
https://doi.org/10.3390/pharmaceutics14040692